This regulation transcends the specific requirements dictated by tumor evolution and holds a broader relevance for pathologies that rely on hematopoietic dysfunction for their medical evolution, including the human hemorrhagic telangiectasia that is caused by congenital mutations in ACVRL1. Here, ACVRL1 is linked to neoplasm.